Effects of omega‐3 supplementation on Ki‐67 and VEGF expression levels and clinical outcomes of locally advanced breast cancer patients treated with neoadjuvant CAF (cyclophosphamide, adriamycin, and fluorouracil) chemotherapy. The gene discussed is VEGFA; the disease is breast carcinoma.